New technologies such as human papillomavirus ( HPV ) testing and vaccination necessitate
comprehensive policy analyses to optimize cervical cancer prevention. To inform future …

Background Several countries have implemented vaccination against human papillomavirus
(HPV) for adolescent girls and must decide whether and how to adapt cervical cancer (CC) …

Following the global call for action by the World Health Organization to eliminate cervical
cancer (CC), we evaluated how each CC policy decision in Norway influenced the timing of CC …

Background Sweden revised their cervical cancer screening program in 2017 to include
cytology-based screening for women aged 23–29 years and primary human papillomavirus (…

Background Attendance to routine cancer screening at repeated intervals is essential for
reducing morbidity and mortality of targeted cancers, yet currently defined quality-assurance …

Several countries have implemented primary human papillomavirus (HPV) testing for
cervical cancer screening. HPV testing enables home‐based, self‐collected sampling (self‐…

It has been argued that activity based payment systems make hospitals focus on the diagnostic
groups that are most beneficial given costs and reimbursement rates. This article tests …

Background Experts have proposed an ‘EVEN FASTER’ concept targeting age-groups
maintaining circulation of human papillomavirus (HPV). We explored effects of the vaccination …

Background Interventions targeting the same disease but at different points along the
disease continuum (eg, screening and vaccination to prevent cervical cancer [CC]) are often …

Background Lack of consensus in management guidelines for women with minor cervical
lesions, coupled with novel screening approaches, such as human papillomavirus (HPV) …